To date, hundreds of registered studies have tested therapies for SLE targeting B cells, long-lived plasma cells, CD22, CD40-CD40 ligand, etc. However, the role of macrophages in SLE has not been fully elucidated and has drawn our attention. This evidence concerns the gene CD22 and systemic lupus erythematosus.